CVS Health Stock News

CVS Health's third-quarter earnings results released Wednesday (Nov. 6) reflected the company's ongoing efforts to adapt to a changing healthcare and retail environment. As it continued to overhaul its operations in response to shifting market dynamics, including the digital transformation of healthcare, CVS faced challenges across its various business units.

CVS Health Corporation (NYSE:CVS ) Q3 2024 Earnings Conference Call November 6, 2024 8:00 AM ET Company Participants David Joyner - President, Chief Executive Officer Tom Cowhey - Executive Vice President, Chief Financial Officer Prem Shah - Group President Larry McGrath - Chief Strategy Officer, Investor Relations Conference Call Participants Lisa Gill - JP Morgan Justin Lake - Wolfe Research ...

CVS Health (CVS) shares surged after the pharmacy chain and healthcare company posted better-than-expected results and new CEO David Joyner made leadership changes as he moves to shake up the struggling firm.

Donald Trump's return to the White House is making big winners out of some S&P 500 stocks. The post 12 Stocks Win Big From Trump's White House Victory appeared first on Investor's Business Daily.

CVS Health stock (NYSE: CVS) is up over 10% on Wednesday, November 6. The broader markets as well as the health insurance stocks are rallying after the Trump victory.

CVS Health Corp (NYSE:CVS) stock is 12% higher at $61.96 at last glance, after the pharmacy giant reported a mixed third quarter.

CVS Health Corp (NYSE:CVS) shares jumped 10.5% pre-market in what may have been a reaction to the US presidential election results, as the drugstore and healthcare services provider reported mixed third-quarter results and failed to provide forward guidance. In the first set of numbers under new CEO David Joyner, who is thought to be leading a review of the group's options, revenues were shown ...

CVS's stock surges after revenue rose well above expectations, while profit missed because of a large charge premium deficiency reserves charge.